These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16942931

  • 21. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of some hemodynamic indices in 15 to 18 year old boys with lipid risk factors for atherosclerosis].
    Mazurowski W.
    Wiad Lek; 1995 Feb; 48(1-12):31-5. PubMed ID: 9638201
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study.
    Shargorodsky M, Michaelova K, Boaz M, Gavish D, Zimlichman R.
    Diabet Med; 2007 Nov; 24(11):1254-60. PubMed ID: 17725634
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects.
    Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM, Tao J.
    Am J Hypertens; 2007 Sep; 20(9):957-64. PubMed ID: 17765136
    [Abstract] [Full Text] [Related]

  • 33. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease.
    Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi R, Chiarotti F, Violi F.
    Eur Heart J; 2007 Mar; 28(5):608-12. PubMed ID: 17298965
    [Abstract] [Full Text] [Related]

  • 34. A dynamic objective evaluation of peripheral arterial disease by near-infrared spectroscopy.
    Manfredini F, Malagoni AM, Felisatti M, Mandini S, Mascoli F, Manfredini R, Basaglia N, Zamboni P.
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):441-8. PubMed ID: 19625198
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I.
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [Abstract] [Full Text] [Related]

  • 37. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.
    Horinaka S, Yabe A, Yagi H, Ishimura K, Hara H, Iemua T, Matsuoka H.
    Angiology; 2009 Nov; 60(4):468-76. PubMed ID: 19015165
    [Abstract] [Full Text] [Related]

  • 38. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL, SMART Study Group.
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [Abstract] [Full Text] [Related]

  • 39. Revascularization decreases 8-isoprostaglandin F2alpha excretion in chronic lower limb ischemia.
    Rossi P, Riutta A, Kuukasjärvi P, Vehmas T, Mucha I, Salenius JP.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):97-101. PubMed ID: 15207525
    [Abstract] [Full Text] [Related]

  • 40. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.